Denis Segota handles mergers and acquisitions (M&A) and private financing transactions. He represents both financial institutions and companies in senior and mezzanine credit financing, royalty monetizations, venture capital, and other private equity financing. He devotes much of his time to companies in the life sciences industry, including both the pharmaceutical and biotechnology sectors, as well as to alternative energy and emerging growth technology companies.
In the life sciences, Denis assists companies with complex joint ventures, strategic alliances, licensing, and other partnering arrangements promoting the research, development, and commercialization of new products. He represents alternative energy and other emerging growth technology companies in financing, acquisitions, divestitures, and other general corporate matters, including advising their boards on corporate governance matters.
Rutgers University School of Law, 1992, J.D.
Rutgers University, 1989, B.S., Cum Laude
Awards and Affiliations
Ranked, Corporate/M&A, New Jersey, Chambers USA (2018)
Ranked, Chambers USA: America's Leading Lawyers for Business (2011–2017)
Ranked, The Legal 500, Mergers and Acquisitions (2014)